Find an expert

Dr Gordon’s research is focused on the formation and maintenance of the blood and lymphatic vascular systems. Vessels form complex branched networks that supply oxygen and nutrients to all body tissues. The signals controlling blood vessel expansion, identity and migration are all downstream of a single, common complex at the cell surface, yet exactly how this diverse range of functions is differentially regulated, depending on the physiological need, remains unknown.

The specific focus of Dr Gordon’s research is to determine the precise molecular signals that control cell adhesion within the vessel wall the surrounding environment. If the signals controlling cell adhesion become deregulated, normal vessel growth and function is lost. This contributes to the progression of a wide range of human diseases, including cancer growth and metastasis, diabetic eye disease and stroke. Dr Gordon aims to use novel biological models, biochemical assays and imaging techniques to better understand vessel biology, which will enable improved treatment of disease and aid in the development of vascularised, bioengineered organs.

Dr Gordon received her Bachelor of Science (2005) and PhD (2011) from The University of Adelaide, after which she undertook six years of postdoctoral studies at Yale University in the USA and Uppsala University in Sweden. With the support of an ARC DECRA Fellowship, Dr Gordon relocated to IMB in 2017 to establish her independent research career as an IMB Fellow. In 2019, she was appointed as Group Leader of the Vessel Dynamics Laboratory.

Dr Gratten completed his undergraduate studies and PhD at The University of Queensland, before undertaking postdoctoral training in evolutionary and quantitative genetics at the University of Sheffield. He then returned to Australia and shifted research focus to psychiatric and neurological genetics, taking up a position as research fellow at the Queensland Brain Institute. In 2013, he was recruited to UQ's Centre for Neurogenetics and Statistical Genomics, and in 2017 was awarded an NHMRC Career Development Fellowship (Level 2). He established the Cognitive Health Genomics group at Mater Research Institute in 2018, with the goal to improve understanding of the etiology of psychiatric and neurological disorders through analysis and integration of whole genome datasets. He has received >$5M in research funding from the NHMRC, Autism Cooperative Research Centre and both Australian (BICARE) and international (Brain & Behavior Research Foundation) philanthropic funders.

Professor Peter Gray is a pioneer of biotechnology research and development in Australia. In 2003 he was appointed AIBN’s inaugural Director and has since overseen the institute’s growth to 450 people and an annual turnover of $40million. Before joining AIBN, he was Professor and Head of Biotechnology at UNSW.

Professor Gray has held academic positions at University College London and the University of California, Berkeley. He has had commercial experience in the US, working for Eli Lilly and Co and the Cetus Corporation. His research collaborations include groups at Stanford University; the University of California, Berkeley; and the University of British Columbia, Vancouver.

He serves on several boards and government committees. He is on the board of Engineering Conferences International, New York, a group that runs global, multi-disciplinary engineering conferences, many of which have played key roles in developing emerging industry sectors. The conferences include cell culture engineering; vaccine technology; and scale-up and manufacturing of cell-based therapies. Professor Gray also serves on the board of Biopharmaceuticals Australia Pty Ltd, the company established to build a GMP grade biopharmaceuticals manufacturing facility in Brisbane, and has been heavily involved in negotiations that led to DSM Biologics becoming the facility’s operator.

Professor Gray is a Fellow and Vice-President of the Australian Academy of Technological Sciences and Engineering and a Fellow of the Australian Institute of Company Directors. He has chaired, served on organising committees for, and given plenary and keynote addresses at many key international conferences. In 2006 he attracted to Sydney and chaired the International Biotechnology Symposium – the first time a conference in the four-yearly series was held in the southern hemisphere. Professor Gray is a founder and past president of the Australian Biotechnology Association (Ausbiotech).

Professor Gray has graduated more than 60 PhD students from his research group, in fields including secondary metabolite bioprocesses; bioconversion of cellulosic substrates; mammalian cell expression of complex proteins; nanoparticles for drug delivery; and the development of stem-cell based bioprocesses. He has twice been listed by Engineers Australia among the top 100 most influential engineers in Australia, and in 2001 was awarded the Australian Government’s Centenary Medal.

Functional genomics and molecular physiology of nodules.

Professor Gresshoff is the Director of the ARC Centre of Excellence for Integrative Legume Research.

His main research interests are the following areas:

1) Functional genomic analysis of nodulation and nitrogen fixation in legumes:

• Molecular components of the control of nodulation (AON) in soybean and Lotus japonicus
• Analysis of ethylene and ABA insensitive legume mutants and transgenics
• Genetic transformation of soybean and Lotus
• Transcription analysis of legumes
• Analysis of acid soil effect on nodulation
• Analysis of Nodulation factor receptors NFR1 and NFR5 in soybean
• Mutational analysis of the GmNARK receptor kinase

2) Sustainable Biofuel Production from Legume Tree Pongamia pinnata:

• Analysis of genetic stability
• Fatty acid analysis
• Field trials
• Clonal propagation
• Gene and promoter discovery
• Functional genomics
• Genetic transformation

Professor Gresshoff is member of the editorial boards of several international journals (among others Molecular Plant, J. Plant Physiology, Symbiosis). He also is a member of the Advisory Committee of the OGTR as well as the Biofuel and Bioenergy Committee of RIRDC.

(she/her)

Dr. Laura Grogan is a qualified veterinarian, Senior Lecturer in Wildlife Science and Leader of the Biodiversity Health Research Team (https://www.biodiversity-health.org/) - a collaborative multiple-university research group focused on finding sustainable solutions for the most challenging threatening processes currently affecting biodiversity.

Dr. Grogan has a background in research on wildlife diseases, ecology and conservation. She's particularly interested in investigating the dynamics, relative importance, and impacts of infectious diseases among other threats affecting wildlife across both individual and population scales, to improve conservation management.

While she works across taxa and methodological approaches, her main study system currently involves the devastating amphibian fungal skin disease, chytridiomycosis, where at the individual scale she focuses on the pathogenesis and amphibian immune response to the disease, untangling the roles of resistance and tolerance in defense against infection. At the population and landscape scale she explores mechanisms underlying persistence in the face of endemic infection, focused on the endangered Fleay's barred frog. She also studies population and infection dynamics of chlamydiosis in koala using a mathematical modelling approach, exploring the relative benefits of different management approaches. In addition to working on amphibian and koala diseases, Laura is a keen birdwatcher, wildlife photographer and artist. She supervises projects across wildlife-related fields (predominantly vertebrates).

You can find out more about her research team here: www.biodiversity-health.org.

Dr. Grogan has been awarded around $1.3 million in research funding since 2018. In late 2019 she was awarded an Australian Research Council Discovery Early Career Researcher Award (DECRA; DE200100490), worth $426,742. This project, titled "Understanding infection tolerance to improve management of wildlife disease", commenced in late 2020. Dr. Grogan was identified as one of the four top-ranked science DECRA awardees by the Australian Academy of Science’s 2020 J G Russell Award, and was also recipient of the highest award of the Wildlife Disease Association Australasia Section with their 2019 Barry L Munday Recognition Award.

PhD and Honours projects are now available in the following areas (plus many more areas - please get in touch if you have an idea):

• Can frogs be ‘vaccinated’ by antifungal treatment of active infections to develop protective immunity to the devastating chytrid fungus? (Principal Supervisor)
• Establishing the conservation status of south-east Queensland’s amphibians - occupancy surveys and species distribution models (Principal Supervisor)
• Tadpoles as a reservoir of the lethal frog chytrid fungal disease – measuring sublethal effects on growth, time to metamorphosis and ability to forage (mouthpart loss) (Principal Supervisor)
• Impacts of chytrid fungus on the survival of juvenile endangered Fleay’s barred frogs, Mixophyes fleayi, and importance for population recruitment (Principal Supervisor)
• Measuring the infection resistance versus tolerance of barred frogs to the devastating chytrid fungal disease to improve management outcomes (Principal Supervisor)
• Mapping the impacts of fire-fighting chemicals on endangered frog habitats (Co-Supervisor)
• Bowra birds: what do long-term monitoring data reveal about bird communities in the semi-arid region? (Co-Supervisor)
• Impacts of fire-fighting chemicals on endangered frogs: Implications for conservation and management (Co-Supervisor)

My research interests are in coral reef ecology and marine parasitology.

I also incorporate other fields in my research including evolutionary biology, molecular biology, parasitology, and animal behaviour. I use field observations to generate hypotheses which are tested using field and laboratory experiments.

Currently, I have research programmes at Lizard Island on the Great Barrier Reef and on campus.

Specific projects include:

Cleaning symbiosis as a model system for developing and testing models of non-kin cooperation in multispecies mutualisms

The ecological significance of cleaning behaviour in reef fishes

The direct and indirect effects of cleaner fish on the coral reef community

Interactions between larval coral reef fish and parasites

The effects of parasites on fish physiology

The taxonomy of gnathiid isopods and their identification using DNA

The role of colour and pattern in communication among animals

The molecular and colour pattern biogeography of cleaner fish

Sustainable amateur marine aquaria

Dr. Wenyi Gu’s early education was conducted in China which include his undergraduate and master’s degrees in veterinary medicine. In 1996, he migrated to Australia and pursued his PhD study in biochemistry & molecular biology at the Australian National University (ANU). After a short period of work at John Curtin Medical School ANU as a junior scientist, he moved to Brisbane in 2001 for his post-doc at the University of Queensland and currently a post-doctoral research fellow at AIBN. He held a Peter Doherty Fellowship (2006-2009) and was further supported by NHMRC to spend 7 months at Harvard University as a visiting fellow in 2008. Since his post-doctoral research he has been working in the area of using RNAi to treat viral diseases and cancers. He also has a strong background in immunology and vaccine development.

I lead a research program with extensive expertise in immunology, particularly in natural killer (NK) cells, focused on developing innovative approaches for treating hard-to-cure diseases like metastatic cancers. Our mission is to improve patient outcomes and extend lives. My research group is based at the Translational Research Institute (TRI).

My dedication to my field has been recognized through numerous peer-reviwed grants as sole-CI or CIA/Principal Investigator, including a NHMRC ECF Peter Doherty Fellowship, an NHMRC Project Grant, an US DoD, a MRFF EMCR among others. Since 2009, I've amassed an impressive portfolio of 96 publications in renowned journals like Blood, Cell Death Dis, JEM, PNAS, Nat Comms, and Nat Immunol with an H-index = 40. My body of work and contributions have been acknowledged with awards such as the 2019 Researcher of the Year by CCA, 2020 QLD Young Tall Poppy Science, 2020 UQ Frazer Institute's Rising Star, 2022 Frazer Institute's Mentor of the Year, 2023 Translational Research Institute - Connecting with the Clinic among others. Recognized as an international leader in my field, I've been instrumental in identifying novel regulators of our immune functions, and developing NK cell-based immunotherapies.

At present, I am a Group Leader / Principal Research Fellow & Associate Professor with the University of Queensland's Frazer Institute. Here, I lead a high-performing research team with a keen focus on developing and innovating immunotherapy approaches for a spectrum of diseases.

Valerie’s research focusses on coastal ecosystem conservation and restoration. She holds an AXA-UNESCO research fellowship on mangrove community forestry for resilient coastal livelihoods, endorsed as an action of the UN Ocean Decade. She co-leads a National Environmental Science Program (NESP) project on carbon abatement and biodiversity enhancements from controlling feral ungulates in wetlands in Australia and is developing a framework to measure verified biodiversity benefits in coastal wetland restoration projects in partnership with CSIRO. She recently led a NESP project on coastal wetland restoration opportunities in Australia for blue carbon and co-benefits for biodiversity, fisheries, water quality, and coastal protection and an Australian Research Council linkage project to identify social and ecological conditions that enable effective mangrove conservation over global and regional scales with partners at The Nature Conservancy and Healthy Land and Water. She has published research on the drivers of global mangrove losses and gains and coastal wetland restoration opportunities. She has co-authored international guidelines on mangrove restoration with Conservation International and incorporation of coastal wetlands into national greenhouse gas inventories with the Australian Government International Blue Carbon Partnerships. Valerie is an experienced ecologist and is a board member of the Society of Ecological Restoration Australasia and a representative of Australia’s Restoration Decade Alliance.

BIO:

Noun (n): I am a Professor in polymer processing in Chemical Engineering, a chief investigator in Advanced Materials Processing and Manufacturing (AMPAM) centre, a chief investigator/director of external links of the ARC industrial transformation training centre (ITTC) in bioplastics and biocomposites, a chief investigator in food and beverage accellerator (FaBA).and a chief investigator in the solving plastic waste cooperative research centre (spwCRC).

Verb (v): I work at the translational research interface between universities and industry. Specifically my research involves rheology, processing and product design of bio-based materials, polymers and nanocomposite materials. I lead translational research projects in biopolymers and biofluid platforms for agrifood, biomedical and high-value manufacturing sectors which attract government and industry funding; and produce patents, licences. industrial know-how as well as fundamental papers.

History (h): I have worked in industry (SRI international, Sola Optical, Moldflow), have worked in five cooperative research centres (CRCs -Food Packaging, Sugar Innovation, Polymers, Fighting Food Waste, Solving Plastic Waste), have acquired and managed continuous government and industry research projects since 1994, was heavily involved in the spinoff of Plantic Technologies from the CRC food packaging in 2002 (and ongoing research support with them until 2016), and was involved in the research that led to the TenasiTech (TPU nanocomposite) spinoff from UQ in 2007.I am a fellow of the institute of chemical engineers (IChemE) and a fellow of the Royal Australian Chemical Institute (RACI). I am on the editorial board of the Plastics, Rubbers and Composites, Starch, the Journal of Renewable Materials, Green Materials and Functional Composite Materials-Springer-Nature. I have experience on the boards of the UQ Dow Centre, the UQ RTA Centre, and the UQ-HBIS Sustainable Steel Innovation Centre. I won IChemE Shedden Uhde Award and Prize for excellence in Chemical Engineering (2004), the CRC Sugar innovation award (2008), the CRCPolymers Chairman’s award for research and commercialisation (2011), and have received the CRC Association Technology Transfer Award, twice, in 2002 and 2015.

Research:

Current projects are focused on developing new sustainable and bio-based polymers and biochemicals from formulation through to degradation/disposal, understanding processing of nanostructured polymers, developing smarter biopolymers and materials for biomedical, drug delivery, food and high value applications, understanding rheology and processing of a range of polymer, foods and liquids and is involved in new initiatives in circular plastics.

Teaching and Learning:

My teaching has spanned Introduction to Engineering Design, Engineering Thermodynamics, Polymer Engineering, Process Economics, Research Thesis and Engineering Management. I am developing new courses in Sustainability and the Circular Economy. My overall teaching goal is to be a relevant, well organised, enthusiastic and empathetic enabler of learning using multiple teaching and learning modes, and be highly connected to current industrial practices and cutting edge research.

International links

I have been a visiting or invited professor at ENSICAEN-University, Caen, Normandy, University of Nottingham, Queen’s University Belfast, the University of Strasbourg and Institut national des sciences appliquées (INSA) de Lyon in France. I have strong international collaborations with the US Department of Agriculture, Albany, USA; Colorado School of Mines, USA; AnoxKaldnes, Sweden; University of Bradford, University of Warwick, University of Nottingham, University of Sheffield, UK, SCION, NZ; Michigan State University, USA, and many Australian universities.

Dr. Anthony Halog: Global Leader in AI-Enabled Circular Economy and Sustainable Systems

Dr. Anthony Halog is an internationally recognized expert in AI-driven circular economy, life cycle assessment (LCA), and sustainable systems engineering. His research integrates artificial intelligence, industrial ecology, and systems thinking to optimize green hydrogen production, bioeconomy transitions, and waste-to-energy systems.

As a Senior Academic at the University of Queensland, Dr. Halog leads research projects funded by ARC, EU Horizon, and industry partners. He has published over 130 high-impact journal articles, advancing knowledge in sustainability science and AI-enabled resource optimization. His work has influenced policy development and industry decarbonization strategies in Australia, Europe, and the Middle East.

Dr. Halog has been awarded prestigious international fellowships, including the OECD Research Fellowship (UK/Finland), DAAD Fellowship (Germany), Japan Society for the Promotion of Science (JSPS) Fellowship, and NSERC Fellowship (Canada). He has held visiting research positions in the UK, Germany, Japan, Saudi Arabia, and Morocco, expanding his global impact on circular economy modeling and AI applications in sustainability.

Beyond academia, he plays a key role in policy advisory and industry collaboration, partnering with the OECD, the United Nations, and the European Commission. As a keynote speaker and editorial board member, he continues to shape global discourse on sustainability transitions and AI-driven resource efficiency.

Associate Professor Emma Hamilton-Williams’ career focuses on understanding how immune tolerance is disrupted leading to the development of the autoimmune disease type 1 diabetes. She received her PhD from the Australian National University in 2001, followed by postdoctoral training in Germany and the Scripps Research Institute in the USA.

In 2012, she started a laboratory at the Frazer Institute, University of Queensland where she investigates the gut microbiota as a potential trigger or therapy target for type 1 diabetes, as well as developing an immunotherapy for type 1 diabetes. The overall aim of her research is to find new ways to prevent or treat the underlying immune dysfunction causing autoimmunity.

She is Chief Scientific Officer for an Australia-wide pregnancy-birth cohort study of children at increased risk of type 1 diabetes, which aims to uncover the environmental drivers of this disease. Her laboratory uses big-data approaches including proteomics, metabolomics and metagenomics to understand the function of the gut microbiota linked to disease.

She recently conducted a clinical trial of a microbiome-targeting biotherapy aimed at restoring a healthy microbiome and immune tolerance, with an ultimate aim of preventing type 1 diabetes.

Dr Pingping Han is currently leading the Epigenetic Nanodiagnostics and Therapeutics Group within the Centre for Orofacial Regeneration, Reconstruction and Rehabilitation (COR3), at the UQ School of Dentistry. Dr Han received her PhD in Biomedical Engineering from the Queensland University of Technology (QUT) in 2014. Dr Han's current research focuses on three themes: a) salivary diagnostics for periodontal disease, b) “cell-free” regenerative therapy for periodontal tissue engineering and c) cellular nano-mechanics on different modified biomaterial substrates.

I am a Research Fellow and Leader in Pain Relief Innovation at AIBN, UQ. My research interests sit at the interface of drug delivery and the pain field. My overarching research goal is to improve the quality of day to day life of patients suffering from chronic pain, by applying nanotechnology to the development of novel highly effective pain-killer products for improving chronic pain management. I am looking for highly motivated postgraduate students.

I also enjoy volunteering within the academic community, most notably as Head of the SBMS ECR Committee and Treasurer for The Queensland Chinese Association of Scientists and Engineers (QCASE). I am currently serving as guest editor of Pain Research and Management.and JoVE Methods Collection.

Research Interests

My research is focusing on nano-based drug formulation and development to improve chronic pain management. I have a broad and unique background in both pharmacology and drug delivery systems, with specific expertise in the development of novel drug products and testing their analgesic efficacy and safety including pharmacokinetic and pharmacodynamic studies. To date, I have established five different techniques to produce painkiller–loaded nanoparticles and nanofibers aimed at improving pain relief for patients where currently available pain-killers either lack efficacy or produce dose-limiting side-effects. For example, there is a small and very potent peptide that has been on the market as a chemical for over 10 years but which cannot be used as a therapeutic due to its short half-life and poor oral bioavailability. In the form of my nanoparticles, that peptide has the potential to become an oral treatment for improving pain management in patients whose pain is currently poorly alleviated by clinically used pain-killers. I have significant expertise in the use of rodent pain models to assess novel analgesics, and I have received excellent training in conducting research in accordance with the stringent requirements of the Quality Management System (quality accreditations (GLP and ISO17025) from NATA). Together, my knowledge, skills and experience will facilitate the efficient translation of my research from the bench to the clinic.

The current focus of the lab is on the development of drug-products to solve one of the largest unmet medical needs in the pain field through use of sustainable materials. 1) We are developing multifunctional sutures including biodegradable pain relief sutures. 2) We are developing my innovative novel nanoparticles, which deliver innate-immune targeting peptides for the treatment of cancer and cancer-related pain. We are establishing a platform for the development of safe, effective delivery for other small molecule peptide drugs in general to pave their way to clinical trials. 3) Our research also investigates the role of C5a and C3a, estrogen, etc. in the pathogenesis of chronic pain including neuropathic pain, cancer-related pain, low back pain and OA pain.

We work in collaboration with other leading Australian and international researchers to stay at the forefront of the drug delivery systems field and the pain field. We also provide preclinical evaluation of novel compounds and formulations.

I undertake multi-disciplinary collaborative research developing mathematical, computational and visualisation approaches and techniques that facilitate the research and education in animal and plant systems.

My major research theme is development of mathematical, computer graphics and simulation approaches and techniques that facilitate the study of genetics, physiology, morphogenesis and ecology at the scale of cells, individual plants and insects and their components. These developments in computational biology are being used to increase our understanding of the dynamics of morphogenesis, and as a tool in applied research and education.

Centre for Solar Biotechnology: Prof Ben Hankamer is the founding director of the Solar Biofuels Consortium (2007) and Centre for Solar Biotechnology (2016) which is focused on developing next generation microalgae systems. These systems are designed to tap into the huge energy resource of the sun (>2300x global energy demand) and capture CO2 to produce a wide-range of products. These include solar fuels (e.g. H2 from water, oil, methane and ethanol), foods (e.g. health foods) and high value products (e.g. vaccines produced in algae). Microalgae systems also support important eco-services such as water purification and CO2 sequestration. The Centre is being launched in 2016/2017 and includes approximately 30 teams with skills ranging from genome sequencing through to demonstration systems optimsation and accompanying techno-economis and life cycle analysis. The Centre teams have worked extensively with industry.

Structural Biology: The photosynthetic machinery is the biological interface of microalgae that taps into the huge energy resource of the sun, powers the biosphere and produces the atmospheric oxygen that supports life on Earth. My team uses high resolution single particle analysis and electron tomography to solve the intricate 3D architecture of the photosynthetic machinery to enable structure guided design of high efficiency microalgae cell lines and advanced artificial solar fuel systems.

CURRENT POSITIONS

· Senior Staff Specialist (Public Health Medicine), Queensland Health

· Principal Research Fellow, Centre for Clinical Research - University of Queensland

RECENT POSITIONS

· General Practitioner, Indooroopilly General Practice

· Director, Queensland Centre for Intellectual and Developmental Disability (to January 2021)

· Senior Medical Officer, Mater Intellectual Disability and Autism Service (to November 2020)

· General Practitioner, Cornwall Street Medical Centre (to November 2020)

How do we feed the world, adapt to and mitigate climate change, and conserve biodiversity? My research addresses these critical questions by quantifying the trade-offs between agricultural production, climate change, and biodiversity in tropical agricultural landscapes. A key focus of my work is agroforestry—the strategic integration of trees into cultivated lands. While agroforests are not a one-size-fits-all solution, my research shows that agroforestry, when informed by a quantitative understanding of these trade-offs, can improve biodiversity and climate outcomes without compromising agricultural productivity.

Through fieldwork and conservation planning, and in collaboration with my wonderful colleagues at the Centre for Biodiversity and Conservation Science (CBCS), I aim to understand how agricultural landscapes can be optimized across large geographic areas, to best meet conflicting goals and improve biodiversity outcomes. The goal of this work is to improve sustainability outcomes across West Africa, where tropical forests have been rapidly converted in order to produce 60% of the world’s cocoa.

Dr April Hastwell is a plant molecular biologist with the School of Agriculture and Food Science at The University of Queensland, Australia. The focus of her research group is on roles of short signalling peptides in root development including in molecular networks controlling the beneficial legume-rhizobia symbiosis and nodule development.